Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline – Xconomy



Acorda Acquires Medtronic Drug, Fills Out Mid-Stage Neurology Pipeline
Xconomy
The Medtronic deal is part of Acorda's grand plan to build up its Phase 2 pipeline of drugs to address unmet medical needs in neurology. The fast-growing company already has two marketed products—dalfampridine (Ampyra) to treat multiple sclerosis,

and more »

DRUG – Google News


Short URL: http://trends-medical.com/?p=440

Posted by on Jul 1 2011. Filed under DRUGS & SUPPLEMENTS. You can follow any responses to this entry through the RSS 2.0. Both comments and pings are currently closed.

Comments are closed

Log in | Medical Trends & News Magazine